Biogen’s R&D pruning hits digital health as biotech scraps 23,000-person cognitive study with Apple
Biogen axed its 23,000-person cognitive health study with Apple phones and watches last week as part of a broader pullback in the biotech’s fledgling digital health unit, per an update to a US federal trials database.
Just two years into its digital health expansion, Biogen is cutting back, per a STAT News report from Wednesday citing Biogen corporate development leader Adam Keeney. The move comes as Biogen’s new leadership consolidates its pipeline, removes 1,000 positions and digests its first acquisition in four years.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.